A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
暂无分享,去创建一个
Sandro Santagata | Marta Barontini | Gabriela Sanso | Márta Korbonits | Julie Ann Sosa | Ashley Grossman | Andrew L Kung | A. Tischler | J. Garber | Cheng Li | M. Korbonits | K. Schneider | S. Santagata | A. Kung | C. Stiles | D. Marsh | P. Dahia | A. Grossman | J. Sosa | Seth M. Arum | V. Nosé | B. Robinson | Ken Ross | Judy Garber | Bruce G Robinson | P. Pigny | I. Ocal | Charles D Stiles | P. M. Dahia | M. Wright | C. Y. Hayashida | M. Barontini | G. Sansó | J. Powers | Richard Hodin | Shannon M Heitritter | Francis D. Moore | Robert P. Dluhy | D. Benn | S. Toledo | Patricia L. M Dahia | Ken N Ross | Matthew E Wright | César Y Hayashida | James F Powers | Arthur S Tischler | Richard Hodin | Shannon Heitritter | Francis Moore | Robert Dluhy | I. Tolgay Ocal | Diana E Benn | Deborah J Marsh | Katherine Schneider | Seth M Arum | Pascal Pigny | Sérgio P. A Toledo | Vania Nosé | Cheng Li | S. Toledo | S. Arum | Bruce G. Robinson | P. Dahia | M. E. Wright | Robert Dluhy | Sérgio P. A. Toledo
[1] N. Socci,et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.
[2] W. Kaelin,et al. Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth , 2003, PLoS biology.
[3] Marjan S. Bolouri,et al. Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.
[4] B. Ackrell. Progress in understanding structure–function relationships in respiratory chain complex II , 2000, FEBS letters.
[5] P. Hogendoorn,et al. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology , 2003, The Journal of pathology.
[6] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[7] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[8] V. de Franciscis,et al. Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells* , 2000, The Journal of Biological Chemistry.
[9] Kan Ding,et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice , 2003, Nature Genetics.
[10] W. Kaelin,et al. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. , 2003, Journal of the American Society of Nephrology : JASN.
[11] S. Chew,et al. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. , 1995, Journal of medical genetics.
[12] G. Semenza. Signal transduction to hypoxia-inducible factor 1. , 2002, Biochemical pharmacology.
[13] K. Nathanson,et al. Pheochromocytoma: the expanding genetic differential diagnosis. , 2003, Journal of the National Cancer Institute.
[14] S. Iwata,et al. Architecture of Succinate Dehydrogenase and Reactive Oxygen Species Generation , 2003, Science.
[15] M. Ivan,et al. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.
[16] George M. Hilliard,et al. Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α* , 2003, The Journal of Biological Chemistry.
[17] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[18] B. Lemire,et al. The Ubiquinone-binding Site of the Saccharomyces cerevisiae Succinate-Ubiquinone Oxidoreductase Is a Source of Superoxide* , 2003, Journal of Biological Chemistry.
[19] E S Husebye,et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.
[20] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Li,et al. Feature extraction and normalization algorithms for high‐density oligonucleotide gene expression array data , 2001, Journal of cellular biochemistry. Supplement.
[22] J. Mesirov,et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.
[23] M. Ivan,et al. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. , 2001, Human molecular genetics.
[24] M. Wigler,et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.
[25] P. Ratcliffe,et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. , 2001, Human molecular genetics.
[26] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[27] P. Rustin,et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.
[28] A. Tischler,et al. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice , 2000, Cell and Tissue Research.
[29] L. Aaltonen,et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. , 2004, American journal of human genetics.
[30] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[31] J. Ritz,et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. , 1999, Human molecular genetics.
[32] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[33] W. Kaelin,et al. Molecular basis of the VHL hereditary cancer syndrome , 2002, Nature Reviews Cancer.
[34] Mirna Lechpammer,et al. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. , 2002, Cancer cell.
[35] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Rustin,et al. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.
[37] Michio Tsuda,et al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes , 1998, Nature.
[38] Okio Hino,et al. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. , 2005, Cancer research.
[39] P. Ratcliffe,et al. Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.
[40] R. Aguiar,et al. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. , 2001, The Journal of clinical endocrinology and metabolism.
[41] Shridar Ganesan,et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. , 2005, Genes & development.
[42] E. Lander,et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.